EGFR and familial pancreatic carcinoma: Within the current translational subgroup analysis of AIO-PK0104 we thus tried to exploratively analyze if the EGFR pathway ‘downstream’ mediators pERK and pAKT could serve as biomarkers in advanced pancreatic cancer.